Clinical Trial Update: Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a biological therapy for multiple myeloma that recurred after bone marrow transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED